2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Can patient-reported outcomes and inflammatory markers define endotype 2 in chronic rhinosinusitis without nasal polyps?

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Chronic rhinosinusitis (CRS) is a heterogeneous disease at the clinical phenotype level (without nasal polyp [CRSsNP] vs with nasal polyp [CRSwNP]) and at the underlying inflammatory endotype level (type 2 vs non-type 2). Whether the endotype is associated with clinical presentation in patients with CRSsNP has yet to be explored in detail.

          Related collections

          Author and article information

          Journal
          Ann Allergy Asthma Immunol
          Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
          Elsevier BV
          1534-4436
          1081-1206
          Apr 2023
          : 130
          : 4
          Affiliations
          [1 ] Upper Airways Research Laboratory, Faculty of Medicine, Ghent University, Ghent, Belgium; Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany. Electronic address: Michaela.Plath@med.uni-heidelberg.de.
          [2 ] Upper Airways Research Laboratory, Faculty of Medicine, Ghent University, Ghent, Belgium.
          [3 ] GESIS-Leibniz-Institute for the Social Sciences, Mannheim, Germany.
          [4 ] Upper Airways Research Laboratory, Faculty of Medicine, Ghent University, Ghent, Belgium; Department of Sense Organs, Sapienza University of Rome, Rome, Italy.
          [5 ] Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Heidelberg, Heidelberg, Germany.
          [6 ] Upper Airways Research Laboratory, Faculty of Medicine, Ghent University, Ghent, Belgium; Otolaryngology Department, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, People's Republic of China; Division of ENT Diseases, CLINTEC, Karolinska Institute, Stockholm, Sweden.
          Article
          S1081-1206(22)01961-5
          10.1016/j.anai.2022.11.020
          36442791
          0e2aeb5c-16a1-4f30-b5d6-e4970953ea73
          History

          Comments

          Comment on this article